We are live on ! Find out more
ACOR

Acorda Therapeutics

Delisted

ACOR was delisted on the 11th of April, 2024.

153 hedge funds and large institutions have $1.4B invested in Acorda Therapeutics in 2013 Q3 according to their latest regulatory filings, with 22 funds opening new positions, 68 increasing their positions, 45 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

51% more repeat investments, than reductions

Existing positions increased: 68 | Existing positions reduced: 45

38% more first-time investments, than exits

New positions opened: 22 | Existing positions closed: 16

25% more call options, than puts

Call options by funds: $4.22M | Put options by funds: $3.36M

6% more capital invested

Capital invested by funds: $1.32B → $1.4B (+$80.1M)

3% more funds holding

Funds holding: 148153 (+5)

0% more funds holding in top 10

Funds holding in top 10: 22 (0)

Holders
153
Holders Change
+5
Holders Change %
+3.38%
% of All Funds
4.96%
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.06%
New
22
Increased
68
Reduced
45
Closed
16
Calls
$4.22M
Puts
$3.36M
Net Calls
+$855K
Net Calls Change
-$11.3M
Name Holding Trade Value Shares
Change
Change in
Stake
Public Sector Pension Investment Board (PSP Investments)
51
Public Sector Pension Investment Board (PSP Investments)
Quebec, Canada
$3.37M +$771K +179 +28%
New York State Common Retirement Fund
52
New York State Common Retirement Fund
New York
$3.31M +$103K +24 +3%
Millennium Management
53
Millennium Management
New York
$3.24M -$1.19M -277 -26%
CCI
54
Columbus Circle Investors
$3.21M +$2.22M +515 +193%
AllianceBernstein
55
AllianceBernstein
Tennessee
$3.12M
SONJCPFA
56
State of New Jersey Common Pension Fund A
New Jersey
$3.08M
Barclays
57
Barclays
United Kingdom
$3.05M -$60.3K -14 -2%
MSA
58
Mason Street Advisors
Wisconsin
$2.94M +$2.88M +668 +1,421%
SCA
59
SAC Capital Advisors
Connecticut
$2.91M -$6.16M -1,429 -67%
Macquarie Group
60
Macquarie Group
Australia
$2.9M -$121K -28 -4%
HCM
61
Highbridge Capital Management
New York
$2.77M +$2.57M +597 +765%
California Public Employees Retirement System
62
California Public Employees Retirement System
California
$2.68M -$30.2K -7 -1%
Deutsche Bank
63
Deutsche Bank
Germany
$2.51M -$10.9M -2,527 -80%
California State Teachers Retirement System (CalSTRS)
64
California State Teachers Retirement System (CalSTRS)
California
$2.5M +$81.8K +19 +3%
SIM
65
Spark Investment Management
New York
$2.31M -$172K -40 -7%
DCM
66
Dupont Capital Management
Delaware
$2.23M -$345K -80 -13%
CCIA
67
Campbell & Co Investment Adviser
Maryland
$2.23M +$2.34M +543 New
AQR Capital Management
68
AQR Capital Management
Connecticut
$2.11M +$1.13M +262 +104%
RhumbLine Advisers
69
RhumbLine Advisers
Massachusetts
$1.87M +$90.5K +21 +5%
PP
70
PDT Partners
New York
$1.85M -$375K -87 -16%
CS
71
Credit Suisse
Switzerland
$1.84M +$818K +190 +74%
NFA
72
Nationwide Fund Advisors
Ohio
$1.68M +$51.7K +12 +3%
Comerica Bank
73
Comerica Bank
Texas
$1.65M +$34.5K +8 +2%
State Board of Administration of Florida Retirement System
74
State Board of Administration of Florida Retirement System
Florida
$1.64M -$228K -53 -12%
ERSOT
75
Employees Retirement System of Texas
Texas
$1.51M +$1.58M +367 New

ACOR Hedge Fund Activity: Q3 2013 in Review

153 of the 3,084 institutional investors tracked by Wall St. Rank reported a position in Acorda Therapeutics (ACOR) for Q3 2013, worth a combined $1.4B — up 6.1% from $1.32B a quarter earlier.

Buyers outnumbered sellers: 22 funds opened new ACOR positions and 16 closed out — a net gain of 6 holders — while 68 added to existing stakes and 45 trimmed.

The largest buyer was Thrivent Financial for Lutherans, adding an estimated $17.9M. The largest seller was Artal Group, cutting an estimated $14.5M.

  • 153 institutional investors held Acorda Therapeutics (ACOR) as of Q3 2013, up from 148 in Q2 2013.
  • Funds reported $1.4B of Acorda Therapeutics stock for Q3 2013, up 6.1% quarter-over-quarter.
  • 22 funds opened new Acorda Therapeutics positions in Q3 2013 and 16 closed out, a net change of +6 holders.
  • The largest Acorda Therapeutics buyer in Q3 2013 was Thrivent Financial for Lutherans, an estimated $17.9M added.
  • The largest Acorda Therapeutics seller in Q3 2013 was Artal Group, an estimated $14.5M sold.

Based on aggregated 13F filings for Q3 2013.